SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-119640
Filing Date
2016-08-16
Accepted
2016-08-16 06:05:23
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v446573_10q.htm 10-Q 937287
2 EXHIBIT 31.1 v446573_ex31-1.htm EX-31.1 36364
3 EXHIBIT 32.1 v446573_ex32-1.htm EX-32.1 9053
  Complete submission text file 0001144204-16-119640.txt   4005342

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT stvf-20160630.xml EX-101.INS 826995
5 XBRL TAXONOMY EXTENSION SCHEMA stvf-20160630.xsd EX-101.SCH 30733
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stvf-20160630_cal.xml EX-101.CAL 24248
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stvf-20160630_def.xml EX-101.DEF 111856
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE stvf-20160630_lab.xml EX-101.LAB 232655
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stvf-20160630_pre.xml EX-101.PRE 232536
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 161834709
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9